Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Hybio Pharmaceutical Co Ltd filed Critical Hybio Pharmaceutical Co Ltd Publication of EP3398960A1 publication Critical patent/EP3398960A1/en Publication of EP3398960A4 publication Critical patent/EP3398960A4/en Application granted granted Critical Publication of EP3398960B1 publication Critical patent/EP3398960B1/en Active legal-status Critical Current Anticipated expiration legal-status Critical Links Espacenet EPO GPI EP Register Global Dossier Discuss Images Classifications CCHEMISTRY
Krivic et al., 2008) ligament-healing (Cerovecki et al., 2010) and has a strong osteogenic effect the in non-union model (Sebecic et al., 1999) (and in other models, such as is observed with rat femoral head osteonecrosis (Gamulin et al., 2013), or alveolar bone loss (Keremi et al., 2009)
Combining them causes a severe 'disulfiram-like' reaction, resulting in intense vomiting, racing heart, and chest pain
409ElmarakbyAAFaulknerJBabanBSalehMASullivanJC
It also possesses mild anti-inflammatory properties, helping to reduce skin redness and sensitivity, and can strengthen the skin barrier function
Pregnant or Breastfeeding Women Glutathione precautions are particularly important for pregnant or breastfeeding women
